Eye bonding sealant glue and preparation method thereof
A sealing glue, eye-use technology, applied in the field of medical materials, can solve the problem of secondary corneal injury, etc., and achieve the effects of strong adhesion, less astigmatism, and uniform tension
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] Embodiment 1, ophthalmic adhesive sealant complete set of raw materials
[0049] The complete set of raw materials for ophthalmic adhesive sealant of this embodiment is composed of a first component and a second component, the first component is an aldylated hyaluronic acid, and the second component is an aminated hyaluronic acid; The ring opening rate of hyaluronic acid is 60-80%, and the grafting rate of hyaluronic acid is 20-40%. Note: In the preparation method of each component, the ring-opening rate of aldylated hyaluronic acid can be controlled to 60-80%, and the grafting rate of aminated hyaluronic acid can be controlled by controlling the feeding ratio and reaction time. 20-40%.
[0050] The first component of this embodiment is made by following method:
[0051] A1. Dissolve hyaluronic acid in purified water to form a 5-100 mg / mL hyaluronic acid solution (in this embodiment: magnetic stirring is used to dissolve overnight). Sodium periodate is dissolved in p...
Embodiment 2
[0070] Embodiment 2, ophthalmic adhesive sealant
[0071] The ophthalmic adhesive sealant of this embodiment is prepared from the complete set of raw materials of the ophthalmic adhesive sealant in Example 1 through the following steps:
[0072] C1. Dissolve the first component in normal saline to form a first solution of 5-20 mg / mL, and dissolve the second component in normal saline to form a second solution of 5-20 mg / mL; in the first solution The concentration of the first component is the same as the concentration of the second component in the second solution.
[0073] Note: In actual use, after step C1, pass each solution through a 0.22μm filter head to sterilize, and then fill them in 5mL pre-filled glass syringes under a sterile environment for use.
[0074] C2. Blend the first solution and the second solution at a volume ratio of 1:1; when blending, use two syringes to communicate with the connectors and then push each other back and forth for 15-30s to mix evenly; i...
Embodiment 3
[0080] Embodiment 3, cytotoxicity detection experiment
[0081] This embodiment is used to detect the cytotoxicity of the gel obtained in Example 2 of Example 2.
[0082] 1. Preparation:
[0083] Blank control solution: DMEM medium containing 10% fetal bovine serum.
[0084] Positive control: 1% zinc diethyldithiocarbamate.
[0085] Negative control: high-density polyethylene, the extraction ratio is every 3cm 2 Add 1mL of leaching solution to high-density polyethylene, and extract for 72h.
[0086] Sample: the gel obtained in Example 2 of Example 2, the extraction ratio is to add 1mL extract for every 0.2g of gel, and extract for 72h. The obtained extract is used as a 100% extraction sample, and then diluted with the extract Samples were leached for 75%, 50%, 25%.
[0087] The solutions or extracts in all groups were all used in DMEM medium containing 10% fetal bovine serum.
[0088] 2. Experimental operation:
[0089] Mouse fibroblast L929 cells were used at 1×10 5 T...
PUM
Property | Measurement | Unit |
---|---|---|
concentration | aaaaa | aaaaa |
shear strength | aaaaa | aaaaa |
shear strength | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com